| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0006 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.42 | 0.002 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |